Previous Article | Next Article 
Infection and Immunity, June 2001, p. 3869-3876, Vol. 69, No. 6
0019-9567/01/$04.00+0 DOI: 10.1128/IAI.69.6.3869-3876.2001
Copyright © 2001, American Society for Microbiology. All rights reserved.
Elevated Cytokine and Chemokine Levels and Prolonged Pulmonary
Airflow Resistance in a Murine Mycoplasma pneumoniae
Pneumonia Model: a Microbiologic, Histologic, Immunologic, and
Respiratory Plethysmographic Profile
Robert D.
Hardy,1,*
Hasan S.
Jafri,1
Kurt
Olsen,1
Meike
Wordemann,1
Jeanine
Hatfield,1
Beverly B.
Rogers,1
Padma
Patel,2
Lynn
Duffy,2
Gail
Cassell,2
George H.
McCracken,1 and
Octavio
Ramilo1
Departments of Pediatric Infectious Diseases and Pathology,
University of Texas Southwestern Medical Center, Dallas,
Texas,1 and Diagnostic Mycoplasma
Laboratory, University of Alabama, Birmingham,
Alabama2
Received 5 February 2001/Returned for modification 6 March
2001/Accepted 26 March 2001
Because Mycoplasma pneumoniae is hypothesized to play
an important role in reactive airway disease/asthma, a comprehensive murine model of M. pneumoniae lower respiratory infection
was established. BALB/c mice were intranasally inoculated once with M. pneumoniae and sacrificed at 0 to 42 days
postinoculation. All mice became infected and developed histologic
evidence of acute pulmonary inflammation, which cleared by 28 days
postinoculation. By contrast, M. pneumoniae persisted in
the respiratory tract for the entire 42 days studied. Tumor necrosis
factor alpha, gamma interferon, interleukin-6 (IL-6), KC (functional
IL-8), MIP-1
, and MCP-1/JE concentrations were significantly
elevated in bronchoalveolar lavage samples, whereas IL-4 and IL-10
concentrations were not significantly elevated. Pulmonary airflow
resistance, as measured by plethysmography, was detected 1 day
postinoculation and persisted even after pulmonary inflammation had
resolved at day 28. Serum anti-M. pneumoniae immunoglobulin
G titers were positive in all mice by 35 days. This mouse model
provides a means to investigate the immunopathogenesis of M. pneumoniae infection and its possible role in reactive airway
disease/asthma.
*
Corresponding author. Mailing address: Dept. of
Pediatrics, University of Texas Southwestern Medical Center, 5323 Harry
Hines Blvd., Dallas, TX 75390-9063. Phone: (214) 648-3720. Fax: (214) 648-2961. E-mail: Robert.Hardy{at}UTSouthwestern.edu.
Infection and Immunity, June 2001, p. 3869-3876, Vol. 69, No. 6
0019-9567/01/$04.00+0 DOI: 10.1128/IAI.69.6.3869-3876.2001
Copyright © 2001, American Society for Microbiology. All rights reserved.
This article has been cited by other articles:
-
Sekine, H., Taguchi, H., Watanabe, H., Kawai, S., Fujioka, Y., Goto, H., Kobayashi, H., Kamiya, S.
(2009). Immunological analysis and pathological examination of gnotobiotic mice monoassociated with Mycoplasma pneumoniae. J Med Microbiol
58: 697-705
[Abstract]
[Full Text]
-
Salvatore, C. M., Techasaensiri, C., Tagliabue, C., Katz, K., Leos, N., Gomez, A. M., McCracken, G. H., Hardy, R. D.
(2009). Tigecycline Therapy Significantly Reduces the Concentrations of Inflammatory Pulmonary Cytokines and Chemokines in a Murine Model of Mycoplasma pneumoniae Pneumonia. Antimicrob. Agents Chemother.
53: 1546-1551
[Abstract]
[Full Text]
-
Chmura, K., Bai, X., Nakamura, M., Kandasamy, P., McGibney, M., Kuronuma, K., Mitsuzawa, H., Voelker, D. R., Chan, E. D.
(2008). Induction of IL-8 by Mycoplasma pneumoniae membrane in BEAS-2B cells. Am. J. Physiol. Lung Cell. Mol. Physiol.
295: L220-L230
[Abstract]
[Full Text]
-
Salvatore, C. M., Fonseca-Aten, M., Katz-Gaynor, K., Gomez, A. M., Hardy, R. D.
(2008). Intranasal Interleukin-12 Therapy Inhibits Mycoplasma pneumoniae Clearance and Sustains Airway Obstruction in Murine Pneumonia. Infect. Immun.
76: 732-738
[Abstract]
[Full Text]
-
Annagur, A., Kendirli, S. G., Yilmaz, M., Altintas, D. U., Inal, A.
(2007). Is There Any Relationship Between Asthma and Asthma Attack in Children and Atypical Bacterial Infections; Chlamydia Pneumoniae, Mycoplasma Pneumoniae and Helicobacter Pylori. J Trop Pediatr
53: 313-318
[Abstract]
[Full Text]
-
Salvatore, C. M., Fonseca-Aten, M., Katz-Gaynor, K., Gomez, A. M., Mejias, A., Somers, C., Chavez-Bueno, S., McCracken, G. H., Hardy, R. D.
(2007). Respiratory Tract Infection with Mycoplasma pneumoniae in Interleukin-12 Knockout Mice Results in Improved Bacterial Clearance and Reduced Pulmonary Inflammation. Infect. Immun.
75: 236-242
[Abstract]
[Full Text]
-
Singh, A M, Busse, W W
(2006). Asthma exacerbations {middle dot} 2: Aetiology. Thorax
61: 809-816
[Abstract]
[Full Text]
-
Bakshi, C. S., Malik, M., Carrico, P. M., Sellati, T. J.
(2006). T-bet Deficiency Facilitates Airway Colonization by Mycoplasma pulmonis in a Murine Model of Asthma. J. Immunol.
177: 1786-1795
[Abstract]
[Full Text]
-
Toews, G. B.
(2005). Impact of bacterial infections on airway diseases. ERR
14: 62-68
[Abstract]
[Full Text]
-
Fonseca-Aten, M., Salvatore, C. M., Mejias, A., Rios, A. M., Chavez-Bueno, S., Katz, K., Gomez, A. M., McCracken, G. H. Jr, Hardy, R. D.
(2005). Evaluation of LBM415 (NVP PDF-713), a Novel Peptide Deformylase Inhibitor, for Treatment of Experimental Mycoplasma pneumoniae Pneumonia. Antimicrob. Agents Chemother.
49: 4128-4136
[Abstract]
[Full Text]
-
Rios, A. M., Fonseca-Aten, M., Mejias, A., Chavez-Bueno, S., Katz, K., Gomez, A. M., McCracken, G. H. Jr., Ramilo, O., Hardy, R. D.
(2005). Microbiologic and Immunologic Evaluation of a Single High Dose of Azithromycin for Treatment of Experimental Mycoplasma pneumoniae Pneumonia. Antimicrob. Agents Chemother.
49: 3970-3973
[Abstract]
[Full Text]
-
Fonseca-Aten, M., Rios, A. M., Mejias, A., Chavez-Bueno, S., Katz, K., Gomez, A. M., McCracken, G. H. Jr., Hardy, R. D.
(2005). Mycoplasma pneumoniae Induces Host-Dependent Pulmonary Inflammation and Airway Obstruction in Mice. Am. J. Respir. Cell Mol. Bio.
32: 201-210
[Abstract]
[Full Text]
-
Waites, K. B., Talkington, D. F.
(2004). Mycoplasma pneumoniae and Its Role as a Human Pathogen. Clin. Microbiol. Rev.
17: 697-728
[Abstract]
[Full Text]
-
Rios, A. M., Mejias, A., Chavez-Bueno, S., Fonseca-Aten, M., Katz, K., Hatfield, J., Gomez, A. M., Jafri, H. S., McCracken, G. H. Jr., Ramilo, O., Hardy, R. D.
(2004). Impact of Cethromycin (ABT-773) Therapy on Microbiological, Histologic, Immunologic, and Respiratory Indices in a Murine Model of Mycoplasma pneumoniae Lower Respiratory Infection. Antimicrob. Agents Chemother.
48: 2897-2904
[Abstract]
[Full Text]
-
Mejias, A., Chavez-Bueno, S., Rios, A. M., Saavedra-Lozano, J., Fonseca Aten, M., Hatfield, J., Kapur, P., Gomez, A. M., Jafri, H. S., Ramilo, O.
(2004). Anti-Respiratory Syncytial Virus (RSV) Neutralizing Antibody Decreases Lung Inflammation, Airway Obstruction, and Airway Hyperresponsiveness in a Murine RSV Model. Antimicrob. Agents Chemother.
48: 1811-1822
[Abstract]
[Full Text]
-
Simmons, W. L., Dybvig, K.
(2003). The Vsa Proteins Modulate Susceptibility of Mycoplasma pulmonis to Complement Killing, Hemadsorption, and Adherence to Polystyrene. Infect. Immun.
71: 5733-5738
[Abstract]
[Full Text]
-
Hardy, R. D., Rios, A. M., Chavez-Bueno, S., Jafri, H. S., Hatfield, J., Rogers, B. B., McCracken, G. H., Ramilo, O.
(2003). Antimicrobial and Immunologic Activities of Clarithromycin in a Murine Model of Mycoplasma pneumoniae-Induced Pneumonia. Antimicrob. Agents Chemother.
47: 1614-1620
[Abstract]
[Full Text]
-
Viscardi, R. M., Kaplan, J., Lovchik, J. C., He, J. R., Hester, L., Rao, S., Hasday, J. D.
(2002). Characterization of a Murine Model of Ureaplasma urealyticum Pneumonia. Infect. Immun.
70: 5721-5729
[Abstract]
[Full Text]
-
Hardy, R. D., Jafri, H. S., Olsen, K., Hatfield, J., Iglehart, J., Rogers, B. B., Patel, P., Cassell, G., McCracken, G. H., Ramilo, O.
(2002). Mycoplasma pneumoniae Induces Chronic Respiratory Infection, Airway Hyperreactivity, and Pulmonary Inflammation: a Murine Model of Infection-Associated Chronic Reactive Airway Disease. Infect. Immun.
70: 649-654
[Abstract]
[Full Text]